This post is a follow up to our May post  on obesity. Why am I so concerned about obesity as it relates to hormone replacement? Because the science shows us that there is increased risk for patients who are insulin resistant, maintain high blood insulin/glucose values and have increased visceral adipose tissue (VAT). VAT, aka [...]